An Aggressive Leukemia Is More Lethal for Black Patients

An Aggressive Leukemia Is More Lethal for Black Patients

By Cara Murez HealthDay ReporterHealthDay Reporter THURSDAY, July 7, 2022 (HealthDay News) — Getting a blood cancer diagnosis is devastating for young people, but it is also far more deadly if the patient is Black, new research shows. The new study, which looked at outcomes for patients with acute myeloid leukemia (AML), highlights an urgent … Read more

Drug Can Keep Leukemia in Remission for Years in Younger Patients

By Robert PreidtHealthDay Reporter TUESDAY, Dec. 14, 2021 (HealthDay News) — For certain leukemia patients, some welcome findings: New research confirms long remissions after treatment with the drug ibrutinib and chemotherapy. The study involved 85 patients with chronic lymphocytic leukemia (CLL). All were 65 or younger, and 46 had more aggressive, unmutated IGHV subtype of … Read more

Combo Therapy Helps Beat a Common Childhood Leukemia

By Robert PreidtHealthDay Reporter FRIDAY, April 2, 2021 (HealthDay News) — Combining stem cell transplants with cutting-edge immunotherapy prevents leukemia relapses in young people and improves their chances of survival, new research suggests. Acute lymphoblastic leukemia is the most common childhood cancer. This study included 50 patients (ages: 4 to 30) with acute lymphoblastic leukemia … Read more

Why Do Black Patients Fare Worse With Blood Cancer?

By Serena McNiffHealthDay Reporter FRIDAY, Dec. 11, 2020 (HealthDay News) — A pair of studies shed new light on why a relatively rare blood cancer — acute myeloid leukemia (AML) — is more deadly among Black patients. The takeaways: Where patients live and their access to quality health care matter. And even when … Read more